X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pegaptanib (283) 283
humans (171) 171
ranibizumab (169) 169
life sciences & biomedicine (163) 163
science & technology (163) 163
bevacizumab (140) 140
ophthalmology (132) 132
vascular endothelial growth factor a - antagonists & inhibitors (111) 111
vascular endothelial growth factor (96) 96
age-related macular degeneration (93) 93
aptamers, nucleotide - therapeutic use (80) 80
macular degeneration (77) 77
macular degeneration - drug therapy (70) 70
angiogenesis inhibitors - therapeutic use (66) 66
male (60) 60
female (59) 59
pegaptanib sodium (57) 57
aged (54) 54
eye diseases (51) 51
choroidal neovascularization - drug therapy (45) 45
treatment outcome (45) 45
pharmacology & pharmacy (44) 44
antibodies, monoclonal, humanized (42) 42
choroidal neovascularization (42) 42
visual acuity (42) 42
animals (40) 40
diabetic retinopathy (40) 40
aflibercept (38) 38
medicine & public health (38) 38
middle aged (38) 38
genetic structures (37) 37
drug therapy (35) 35
intravitreal injections (35) 35
neovascularization (34) 34
vitreous body (34) 34
injections (33) 33
macular degeneration - complications (33) 33
antibodies, monoclonal - therapeutic use (32) 32
aptamers, nucleotide - administration & dosage (32) 32
diabetic macular edema (30) 30
fluorescein angiography (30) 30
aged, 80 and over (29) 29
anti-vegf (28) 28
aptamers, nucleotide - adverse effects (28) 28
care and treatment (28) 28
dosage and administration (28) 28
vegf (28) 28
tomography, optical coherence (27) 27
age related macular degeneration (26) 26
angiogenesis inhibitors - administration & dosage (26) 26
photodynamic therapy (26) 26
physiological aspects (26) 26
research (26) 26
angiogenesis inhibitors - adverse effects (25) 25
sense organs (25) 25
choroidal neovascularization - etiology (24) 24
macular edema - drug therapy (24) 24
follow-up studies (21) 21
angiogenesis (20) 20
intellectual property (20) 20
macular degeneration - physiopathology (20) 20
prospective studies (20) 20
retrospective studies (20) 20
diabetic retinopathy - drug therapy (19) 19
visual acuity - drug effects (19) 19
visual acuity - physiology (19) 19
macugen (18) 18
review (17) 17
cancer (16) 16
diabetes (16) 16
photochemotherapy (16) 16
verteporfin (16) 16
analysis (15) 15
clinical ophthalmology (15) 15
edema (15) 15
intravitreal injection (15) 15
wet macular degeneration - drug therapy (15) 15
health aspects (14) 14
internal medicine (14) 14
triamcinolone (14) 14
antibodies, monoclonal, humanized - therapeutic use (13) 13
clinical trials (13) 13
drug therapy, combination (13) 13
optical coherence tomography (13) 13
proliferative diabetic retinopathy (13) 13
vascular endothelial growth factor a - metabolism (13) 13
angiogenesis inhibitors (12) 12
antibodies, monoclonal - administration & dosage (12) 12
antibodies, monoclonal - adverse effects (12) 12
macular degeneration - pathology (12) 12
porphyrins - therapeutic use (12) 12
aptamer (11) 11
choroidal neovascularization - diagnosis (11) 11
choroidal neovascularization - physiopathology (11) 11
photosensitizing agents - therapeutic use (11) 11
research and development (11) 11
adult (10) 10
aptamers, nucleotide - economics (10) 10
aptamers, nucleotide - pharmacology (10) 10
clinical trials as topic (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (315) 315
German (11) 11
Turkish (8) 8
French (4) 4
Czech (3) 3
Polish (3) 3
Russian (3) 3
Spanish (3) 3
Chinese (1) 1
Japanese (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Experimental and therapeutic medicine, ISSN 1792-0981, 12/2017, Volume 14, Issue 6, pp. 6002 - 6006
The aim of the present study was to report the importance of pegaptanib sodium (PGSD) injection treatment for vascular active vitreoretinopathy (VAVR). A total... 
Vascular active vitreoretinopathy | Visual acuity | Inflammation | Pegaptanib sodium | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine
Journal Article
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, ISSN 0941-293X, 2/2014, Volume 111, Issue 2, pp. 113 - 120
Neben der topischen, periokulären und systemischen Gabe hat sich die intravitreale Injektion in den letzten Jahren als weiteres Standardverfahren der... 
Medicine & Public Health | Halbwertszeit | Ranibizumab | Ophthalmology | Half-life | Aflibercept | Pegaptanib | Bevacizumab
Journal Article